| UniProt ID | SNP23_HUMAN | |
|---|---|---|
| UniProt AC | O00161 | |
| Protein Name | Synaptosomal-associated protein 23 | |
| Gene Name | SNAP23 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 211 | |
| Subcellular Localization |
Cell membrane Peripheral membrane protein. Cell membrane Lipid-anchor. Cell junction, synapse, synaptosome. Mainly localized to the plasma membrane. |
|
| Protein Description | Essential component of the high affinity receptor for the general membrane fusion machinery and an important regulator of transport vesicle docking and fusion.. | |
| Protein Sequence | MDNLSSEEIQQRAHQITDESLESTRRILGLAIESQDAGIKTITMLDEQKEQLNRIEEGLDQINKDMRETEKTLTELNKCCGLCVCPCNRTKNFESGKAYKTTWGDGGENSPCNVVSKQPGPVTNGQLQQPTTGAASGGYIKRITNDAREDEMEENLTQVGSILGNLKDMALNIGNEIDAQNPQIKRITDKADTNRDRIDIANARAKKLIDS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDNLSSEE -------CCCCCHHH | 7.51 | 20068231 | |
| 5 | Phosphorylation | ---MDNLSSEEIQQR ---CCCCCHHHHHHH | 41.79 | 23401153 | |
| 5 (in isoform 1) | Phosphorylation | - | 41.79 | - | |
| 6 | Phosphorylation | --MDNLSSEEIQQRA --CCCCCHHHHHHHH | 42.27 | 29255136 | |
| 6 (in isoform 1) | Phosphorylation | - | 42.27 | - | |
| 17 | Phosphorylation | QQRAHQITDESLEST HHHHHHCCHHHHHHH | 27.43 | 23898821 | |
| 20 | Phosphorylation | AHQITDESLESTRRI HHHCCHHHHHHHHHH | 40.00 | 23401153 | |
| 20 (in isoform 1) | Phosphorylation | - | 40.00 | - | |
| 23 | Phosphorylation | ITDESLESTRRILGL CCHHHHHHHHHHHHH | 32.29 | 23401153 | |
| 23 (in isoform 1) | Phosphorylation | - | 32.29 | - | |
| 24 | Phosphorylation | TDESLESTRRILGLA CHHHHHHHHHHHHHH | 18.00 | 29255136 | |
| 24 (in isoform 1) | Phosphorylation | - | 18.00 | - | |
| 34 | Phosphorylation | ILGLAIESQDAGIKT HHHHHHHCCCCCCEE | 27.52 | 30266825 | |
| 34 (in isoform 1) | Phosphorylation | - | 27.52 | - | |
| 40 (in isoform 1) | Ubiquitination | - | 32.72 | 21906983 | |
| 40 (in isoform 2) | Ubiquitination | - | 32.72 | 21906983 | |
| 40 | Ubiquitination | ESQDAGIKTITMLDE HCCCCCCEEEEEHHH | 32.72 | 21906983 | |
| 44 | Sulfoxidation | AGIKTITMLDEQKEQ CCCEEEEEHHHHHHH | 3.82 | 21406390 | |
| 49 (in isoform 1) | Ubiquitination | - | 45.43 | 21906983 | |
| 49 | Ubiquitination | ITMLDEQKEQLNRIE EEEHHHHHHHHHHHH | 45.43 | 21906983 | |
| 49 (in isoform 2) | Ubiquitination | - | 45.43 | 21906983 | |
| 64 (in isoform 1) | Ubiquitination | - | 55.31 | 21906983 | |
| 64 | Ubiquitination | EGLDQINKDMRETEK HHHHHHHHHHHHHHH | 55.31 | 21906983 | |
| 64 (in isoform 2) | Ubiquitination | - | 55.31 | 21906983 | |
| 69 | Phosphorylation | INKDMRETEKTLTEL HHHHHHHHHHHHHHH | 32.20 | 23312004 | |
| 71 | Ubiquitination | KDMRETEKTLTELNK HHHHHHHHHHHHHHH | 57.14 | - | |
| 72 | Phosphorylation | DMRETEKTLTELNKC HHHHHHHHHHHHHHH | 32.45 | 23312004 | |
| 74 | Phosphorylation | RETEKTLTELNKCCG HHHHHHHHHHHHHCC | 43.59 | 23312004 | |
| 79 | S-palmitoylation | TLTELNKCCGLCVCP HHHHHHHHCCEEEEC | 1.85 | 31142470 | |
| 80 | S-palmitoylation | LTELNKCCGLCVCPC HHHHHHHCCEEEECC | 5.07 | 31142470 | |
| 83 | S-palmitoylation | LNKCCGLCVCPCNRT HHHHCCEEEECCCCC | 1.47 | 31142470 | |
| 85 | S-palmitoylation | KCCGLCVCPCNRTKN HHCCEEEECCCCCCC | 2.87 | 31142470 | |
| 87 | S-palmitoylation | CGLCVCPCNRTKNFE CCEEEECCCCCCCCC | 4.56 | 31142470 | |
| 91 | Ubiquitination | VCPCNRTKNFESGKA EECCCCCCCCCCCCE | 57.30 | - | |
| 95 | Phosphorylation | NRTKNFESGKAYKTT CCCCCCCCCCEEECC | 41.26 | 22817900 | |
| 97 | Acetylation | TKNFESGKAYKTTWG CCCCCCCCEEECCCC | 58.80 | 25953088 | |
| 97 | Ubiquitination | TKNFESGKAYKTTWG CCCCCCCCEEECCCC | 58.80 | - | |
| 99 | Phosphorylation | NFESGKAYKTTWGDG CCCCCCEEECCCCCC | 16.62 | 28450419 | |
| 100 | Ubiquitination | FESGKAYKTTWGDGG CCCCCEEECCCCCCC | 44.32 | - | |
| 101 | Phosphorylation | ESGKAYKTTWGDGGE CCCCEEECCCCCCCC | 18.33 | 22167270 | |
| 102 | Phosphorylation | SGKAYKTTWGDGGEN CCCEEECCCCCCCCC | 24.25 | 22167270 | |
| 108 (in isoform 1) | Phosphorylation | - | 61.13 | - | |
| 110 | Phosphorylation | WGDGGENSPCNVVSK CCCCCCCCCCCEEEC | 26.91 | 19664994 | |
| 112 | S-palmitoylation | DGGENSPCNVVSKQP CCCCCCCCCEEECCC | 6.40 | 21044946 | |
| 112 | S-nitrosylation | DGGENSPCNVVSKQP CCCCCCCCCEEECCC | 6.40 | 2212679 | |
| 116 | Phosphorylation | NSPCNVVSKQPGPVT CCCCCEEECCCCCCC | 22.69 | 23927012 | |
| 117 | Ubiquitination | SPCNVVSKQPGPVTN CCCCEEECCCCCCCC | 49.23 | - | |
| 123 | Phosphorylation | SKQPGPVTNGQLQQP ECCCCCCCCCCCCCC | 36.44 | 26074081 | |
| 131 | Phosphorylation | NGQLQQPTTGAASGG CCCCCCCCCCCCCCC | 33.26 | 21945579 | |
| 132 | Phosphorylation | GQLQQPTTGAASGGY CCCCCCCCCCCCCCC | 31.35 | 21945579 | |
| 132 (in isoform 2) | Ubiquitination | - | 31.35 | 21906983 | |
| 136 | Phosphorylation | QPTTGAASGGYIKRI CCCCCCCCCCCEEEC | 32.01 | 21945579 | |
| 139 | Phosphorylation | TGAASGGYIKRITND CCCCCCCCEEECCCC | 13.54 | 21945579 | |
| 141 (in isoform 1) | Ubiquitination | - | 29.30 | 21906983 | |
| 141 | Ubiquitination | AASGGYIKRITNDAR CCCCCCEEECCCCCC | 29.30 | 21906983 | |
| 144 | Phosphorylation | GGYIKRITNDAREDE CCCEEECCCCCCHHH | 30.95 | 28270605 | |
| 157 | Phosphorylation | DEMEENLTQVGSILG HHHHHHHHHHHHHHH | 32.56 | 26657352 | |
| 161 | Phosphorylation | ENLTQVGSILGNLKD HHHHHHHHHHHHHHH | 18.78 | 25159151 | |
| 169 | Sulfoxidation | ILGNLKDMALNIGNE HHHHHHHHHHHCCCC | 4.34 | 21406390 | |
| 185 (in isoform 1) | Ubiquitination | - | 32.28 | 21906983 | |
| 185 | Ubiquitination | DAQNPQIKRITDKAD CCCCCCHHHHCCCCC | 32.28 | 2190698 | |
| 190 | Ubiquitination | QIKRITDKADTNRDR CHHHHCCCCCCCHHH | 39.24 | - | |
| 193 | Phosphorylation | RITDKADTNRDRIDI HHCCCCCCCHHHHHH | 36.69 | 27470641 | |
| 211 | Phosphorylation | RAKKLIDS------- HHHHHHCC------- | 34.82 | 26074081 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 23 | S | Phosphorylation | Kinase | KPCA | P17252 | PhosphoELM |
| 23 | S | Phosphorylation | Kinase | PRKCA | P05696 | GPS |
| 24 | T | Phosphorylation | Kinase | KPCA | P17252 | PhosphoELM |
| 24 | T | Phosphorylation | Kinase | PRKCA | P05696 | GPS |
| 95 | S | Phosphorylation | Kinase | IKBKB | O14920 | GPS |
| 95 | S | Phosphorylation | Kinase | PRKCA | P05696 | GPS |
| 95 | S | Phosphorylation | Kinase | PKM | P14618 | PSP |
| 161 | S | Phosphorylation | Kinase | KPCA | P17252 | PhosphoELM |
| 161 | S | Phosphorylation | Kinase | PRKCA | P05696 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNP23_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNP23_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-102 AND SER-110, AND MASS SPECTROMETRY. | |
| "Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 1-12, AND ACETYLATION AT MET-1. | |
| Palmitoylation | |
| Reference | PubMed |
| "Site-specific analysis of protein S-acylation by resin-assistedcapture."; Forrester M.T., Hess D.T., Thompson J.W., Hultman R., Moseley M.A.,Stamler J.S., Casey P.J.; J. Lipid Res. 52:393-398(2011). Cited for: PALMITOYLATION AT CYS-79; CYS-80; CYS-83; CYS-85; CYS-87 AND CYS-112. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-102 AND SER-110, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110, AND MASSSPECTROMETRY. | |